| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corporation | 26 | Q3 2019 | 1.7% |
| Thermo Fisher Scientific, Inc. | 26 | Q3 2019 | 1.7% |
| JPMorgan Chase & Co. | 26 | Q3 2019 | 1.6% |
| Pfizer, Inc. | 26 | Q3 2019 | 1.4% |
| Johnson & Johnson | 26 | Q3 2019 | 1.4% |
| Gilead Sciences, Inc. | 26 | Q3 2019 | 2.2% |
| Cisco Systems, Inc. | 26 | Q3 2019 | 1.3% |
| Verizon Communications, Inc. | 26 | Q3 2019 | 1.4% |
| Merck & Company, Inc. | 26 | Q3 2019 | 1.6% |
| Philip Morris Int'l, Inc. | 26 | Q3 2019 | 1.2% |
View FORESTERS INVESTMENT MANAGEMENT COMPANY, INC.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PHIBRO ANIMAL HEALTH CORP | February 12, 2019 | 601,233 | 3.0% |
| BLACKHAWK NETWORK HOLDINGS, INCSold out | January 06, 2016 | 0 | 0.0% |
| Health Insurance Innovations, Inc.Sold out | January 06, 2016 | 0 | 0.0% |
| KENSEY NASH CORP | February 14, 2001 | 305,000 | 2.9% |
View FORESTERS INVESTMENT MANAGEMENT COMPANY, INC.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| SC 13G/A | 2019-02-12 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-13 |
| 13F-HR | 2018-05-11 |
| 13F-HR | 2018-02-14 |
| 13F-HR | 2017-11-13 |
View FORESTERS INVESTMENT MANAGEMENT COMPANY, INC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.